Brokers Issue Forecasts for Cardinal Health, Inc.’s Q1 2025 Earnings (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAH) – Research analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for Cardinal Health in a research report issued to clients and investors on Monday, April 22nd. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $1.73 for the quarter, down from their prior forecast of $1.83. Leerink Partnrs has a “Outperform” rating on the stock. The consensus estimate for Cardinal Health’s current full-year earnings is $7.28 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q2 2025 earnings at $1.84 EPS, Q3 2025 earnings at $2.14 EPS, Q4 2025 earnings at $1.96 EPS and FY2025 earnings at $7.67 EPS.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. During the same quarter in the previous year, the company posted $1.32 EPS. Cardinal Health’s quarterly revenue was up 11.6% compared to the same quarter last year.

Several other brokerages have also recently weighed in on CAH. TheStreet cut shares of Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. Barclays initiated coverage on Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target for the company. SVB Leerink began coverage on Cardinal Health in a research report on Monday, February 26th. They set an “outperform” rating and a $125.00 price objective for the company. Argus upgraded Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. Finally, UBS Group raised their price target on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a report on Monday, February 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $103.07.

Cardinal Health Price Performance

Cardinal Health stock opened at $102.83 on Tuesday. The business has a 50 day moving average of $109.58 and a 200-day moving average of $104.50. Cardinal Health has a 1 year low of $77.56 and a 1 year high of $116.04. The company has a market capitalization of $25.01 billion, a P/E ratio of 40.48, a P/E/G ratio of 1.04 and a beta of 0.68.

Hedge Funds Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Aaron Wealth Advisors LLC raised its stake in Cardinal Health by 1.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after buying an additional 97 shares during the period. Schechter Investment Advisors LLC lifted its holdings in shares of Cardinal Health by 4.1% in the 4th quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $250,000 after purchasing an additional 98 shares in the last quarter. J. W. Coons Advisors LLC grew its position in Cardinal Health by 0.6% in the 4th quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock valued at $1,681,000 after purchasing an additional 100 shares during the period. Edmonds Duncan Registered Investment Advisors LLC grew its position in Cardinal Health by 5.0% in the 1st quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company’s stock valued at $234,000 after purchasing an additional 100 shares during the period. Finally, Cypress Capital Group increased its stake in Cardinal Health by 0.7% during the 3rd quarter. Cypress Capital Group now owns 17,133 shares of the company’s stock valued at $1,487,000 after purchasing an additional 111 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is currently 78.74%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.